Amit Sachdev sold $898K of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 25, disclosed Feb 26, 1 day later.

Value, as filed

$898K

1,846 sh × $486.35

Executed

Feb 25

the trade date, as filed

Disclosed

Feb 26

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AS Amit Sachdev EVP Chief Patient & Ext Af Off profile →

Amit Sachdev (EVP Chief Patient & Ext Af Off) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $27.5M of VRTX (58,613 sh across 8 lots, as filed), executed Feb 19.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 90 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Amit Sachdev in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $27.5M
58,613 sh across 8 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET